CKD Corporation
Notice Regarding Status of Treasury Stock Acquisition
Based on a board resolution, CKD Corporation acquired 490,400 ordinary shares. The total acquisition amount was 2,278,991,800 yen, and the period was from October 27, 2026 to October 31, 2026, implemented via market purchases. An upper limit of 1,300,000 shares (1.94% of total outstanding shares) is assumed, and the acquisition period may be extended until December 30, 2026.
Key Figures
- 490,400 shares: Total number of shares acquired
- 2,278,991,800 yen: Total acquisition price
- 1,300,000 shares: Maximum number of shares to be acquired (at time of resolution)
AI要約
Overview of Capital Policy
CKD Corporation decided to carry out a treasury stock acquisition based on a board resolution dated October 7, 2026. In this announcement, the type of shares to be acquired is ordinary shares, the total number of shares to be acquired is 490,400 shares, and the total acquisition price is 2,278,991,800 yen. The acquisition period is from October 27, 2026 to October 31, 2026 (based on contract date), and the acquisition method is market purchase.
Future Plans and Notes
An upper limit of 1,300,000 shares (representing 1.94% of total outstanding shares) has been set, and the period may be extended until December 30, 2026 depending on additional acquisition circumstances. It is possible that some or all acquisitions may not be carried out due to market conditions. No specific cancellation plan has been disclosed.
CKD Corporation
Company overview · Stock price · Financial data · All IR
